The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Budavari, S. (1998) · Royal Society of Chemistry eBooks · Cited by 2,741
Artursson, P., Palm, K., & Luthman, K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00128-9 · Cited by 1,543
Analytical profiles of drug substances
(1975) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600640947 · Cited by 1,491
Martindale. The Extra Pharmacopoeia.
(1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-98-5-687_2 · Cited by 1,111
Kim, R. B., Fromm, M. F., Wandel, C., Leake, B., Wood, A. J., Roden, D. M., & Wilkinson, G. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1269 · Cited by 1,054
Hörter, D., & Dressman, J. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00130-7 · Cited by 819
Self-citation(2001) · Drugs and the Pharmaceutical Sciences · doi:10.1201/9780824741969.axh · Cited by 818
Clinical Pharmacokinetics of Metformin
Scheen, A. J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630050-00003 · Cited by 636
Dose-Related Kinetics of Aspirin: Presystemic Acetylation of Platelet Cyclooxygenase
Pedersen, A. K., & FitzGerald, G. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411083111902 · Cited by 558
Comparison Between Permeability Coefficients in Rat and Human Jejunum
Fagerholm, U., Johansson, M., & Lennernäs, H. (1996) · Pharmaceutical Research · doi:10.1023/a:1016065715308 · Cited by 438
Pharmacokinetics and Tissue Penetration of Fluconazole in Humans
Brammer, K. W., Farrow, P. R., & Faulkner, J. K. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.supplement_3.s318 · Cited by 429
P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs
Fromm, M. F. (2000) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38069 · Cited by 399
Pharmacokinetics and Pharmacodynamics of the Nitroimidazole Antimicrobials
Lamp, K. C., Freeman, C. D., Klutman, N. E., & Lacy, M. K. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936050-00004 · Cited by 388
Pharmacokinetics of acyclovir after intravenous and oral administration
de Miranda, P., & Blum, M. R. (1983) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/12.suppl_b.29 · Cited by 381
Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis
TELLIER, P., PAYCHA, F., ANTONY, I., NITENBERG, A., VALEYRE, D., FOULT, J., & BATTESTI, J. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90536-0 · Cited by 370
Pharmacokinetics and Pharmacodynamics of Lumefantrine (Benflumetol) in Acute Falciparum Malaria
Ezzet, F., van Vugt, M., Nosten, F., Looareesuwan, S., & White, N. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.697-704.2000 · Cited by 354
Clinical Pharmacokinetics and Pharmacodynamics of Artemether-Lumefantrine
White, N. J., van Vugt, M., & Ezzet, F. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937020-00002 · Cited by 351
Pharmacokinetics of Metformin After Intravenous and Oral Administration to Man
Pentik�inen, P. J., Neuvonen, P. J., & Penttil�, A. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00562061 · Cited by 348
Clinical Pharmacokinetics of H1-Receptor Antagonists (The Antihistamines)
Paton, D. M., & Webster, D. R. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510060-00002 · Cited by 334
Clinical Pharmacokinetics of the Salicylates
Needs, C. J., & Brooks, P. M. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510020-00004 · Cited by 320
Pharmacokinetics of Quinine, Chloroquine and Amodiaquine: Clinical Implications
Krishna, S., & White, N. J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630040-00002 · Cited by 304
Pharmacokinetics of Haloperidol
Froemming, J. S., Lam, Y. W. F., Jann, M. W., & Davis, C. M. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198917060-00004 · Cited by 291
Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration
Rawlins, M. D., Henderson, D. B., & Hijab, A. R. (1977) · European Journal of Clinical Pharmacology · doi:10.1007/bf00607678 · Cited by 284
Klotz, U. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510040-00001 · Cited by 277
Clinical Pharmacokinetics of Lamivudine
Johnson, M. A., Moore, K. H. P., Yuen, G. J., Bye, A., & Pakes, G. E. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936010-00004 · Cited by 275
Clinical Pharmacokinetics of Digoxin
Iisalo, E. (1977) · Clinical Pharmacokinetics · doi:10.2165/00003088-197702010-00001 · Cited by 265
Avdeef, A., Berger, C. M., & Brownell, C. (2000) · Pharmaceutical Research · doi:10.1023/a:1007526826979 · Cited by 260
Clinical Pharmacokinetics of Fluconazole
Debruyne, D., & Ryckelynck, J.-P. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324010-00002 · Cited by 255
Absorption Classification of Oral Drugs Based on Molecular Surface Properties
Bergström, C. A. S., Strafford, M., Lazorova, L., Avdeef, A., Luthman, K., & Artursson, P. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020986i · Cited by 247
Physiological disposition of verapamil in man
SCHOMERUS, M., SPIEGELHALDER, B., STIEREN, B., & EICHELBAUM, M. (1976) · Cardiovascular Research · doi:10.1093/cvr/10.5.605 · Cited by 243
Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans
Zempleni, J., Galloway, Jr., & McCormick, D. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.1.54 · Cited by 238
Clinical Pharmacokinetics of Ciprofloxacin
Vance-Bryan, K., Guay, D. R. P., & Rotschafer, J. C. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199019060-00003 · Cited by 222
Pharmacokinetics of Artemisinin-Type Compounds
Navaratnam, V., Mansor, S. M., Sit, N.-W., Grace, J., Li, Q., & Olliaro, P. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039040-00002 · Cited by 220
Grapefruit juice enhances the bioavailability of the HIV protease inhibitor saquinavir in man
Kupferschmidt, H. H. T., Fattinger, K. E., Ha, H. R., Follath, F., & Krahenbuhl, S. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00687.x · Cited by 214
Experimental and Computational Screening Models for Prediction of Aqueous Drug Solubility
Bergström, C. A. S., Norinder, U., Luthman, K., & Artursson, P. (2002) · Pharmaceutical Research · doi:10.1023/a:1014224900524 · Cited by 196
Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate.
Morgan, D., Paull, J., Richmond, B., Wilson‐Evered, E., & Ziccone, S. (1986) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1986.tb02939.x · Cited by 196
Clinical Pharmacokinetics of Verapamil, Nifedipine and Diltiazem
Echizen, H., & Eichelbaum, M. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611060-00002 · Cited by 186
Link between drug absorption solubility and permeability measurements in Caco-2 cells
Pade, V., & Stavchansky, S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980111k · Cited by 186
An Integrated Model for Determining Causes of Poor Oral Drug Absorption
Yu, L. X. (1999) · Pharmaceutical Research · doi:10.1023/a:1018911728161 · Cited by 185
Clinical Pharmacokinetics of Sulphasalazine
Das, K. M., & Dubin, R. (1976) · Clinical Pharmacokinetics · doi:10.2165/00003088-197601060-00002 · Cited by 182
Hoskin, P., Hanks, G., Aherne, G. W., Chapman, D., Littleton, P., & Filshie, J. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb05399.x · Cited by 170
Examination of the Solubilization of Drugs by Bile Salt Micelles
Wiedmann, T. S., & Kamel, L. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10158 · Cited by 169
Clinical Pharmacokinetics of Cimetidine
Somogyi, A. A., & Gugler, R. (1983) · Clinical Pharmacokinetics · doi:10.2165/00003088-198308060-00001 · Cited by 156
Pharmacokinetics of Captopril in Healthy Subjects and in Patients with Cardiovascular Diseases
Duchin, K. L., McKinstry, D. N., Cohen, A. I., & Migdalof, B. H. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198814040-00002 · Cited by 151
Mandagere, A. K., Thompson, T. N., & Hwang, K. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010152k · Cited by 143
Pharmacokinetics of oral and intravenous rifampicin during chronic administration
Loos, U., Musch, E., Jensen, J. C., Mikus, G., Schwabe, H. K., & Eichelbaum, M. F. (1985) · Journal of Molecular Medicine · doi:10.1007/bf01733779 · Cited by 141
Jung, H., Medina, L., García, L., Fuentes, I., & Moreno‐Esparza, R. (1998) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1998.tb03303.x · Cited by 137
Oral absorption of the HIV protease inhibitors: a current update
Williams, G. C., & Sinko, P. J. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00027-7 · Cited by 136
Factors affecting the absolute bioavailability of nifedipine.
Rashid, T. J., Martin, U., Clarke, H., Waller, D., Renwick, A., & George, C. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04534.x · Cited by 133
Hammarlund, M., Paalzow, L., & Odlind, B. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00630286 · Cited by 132
Clinical Pharmacokinetics of Allopurinol
Murrell, G. A. C., & Rapeport, G. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611050-00001 · Cited by 131
Pharmacokinetic profiles of ciprofloxacin after single intravenous and oral doses
Lettieri, J., Rogge, M. C., Kaiser, L., ECHOLS, R. M., & Heller, A. H. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.5.993 · Cited by 130
Pharmacokinetics and Bioavailability of Cimetidine in Humans
Pedersen, P. V., & Miller, R. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600690408 · Cited by 130
Increased systemic availability of albendazole when taken with a fatty meal
Lange, H., Eggers, R., & Bircher, J. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00540964 · Cited by 129
Rochdi, M., Sabouraud, A. E., Girre, C., Venet, R., & Scherrmann, J. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00194404 · Cited by 126
Effect of altered gastric emptying and gastrointestinal motility on metformin absorption
Marathe, P. H., Wen, Y., Norton, J., Greene, D. S., Barbhaiya, R. H., & Wilding, I. R. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00264.x · Cited by 124
Comparative Pharmacokinetics of Antiviral Nucleoside Analogues
Morse, G. D., Shelton, M. J., & OʼDonnell, A. M. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324020-00002 · Cited by 124
Ishihama, Y., Nakamura, M., Miwa, T., Kajima, T., & Asakawa, N. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10087 · Cited by 124
Robertson, D., Wood, N., Everest, H., Monks, K., Waller, D., Renwick, A., & George, C. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03506.x · Cited by 123
Tallaksen, C. M. E., Sande, S. A., B�hmer, T., Bell, H., & Karlsen, J. R. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315284 · Cited by 120
Clinical Pharmacokinetics of Clofazimine: A Review
Holdiness, M. R. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198916020-00002 · Cited by 120
Phenytoin: Pharmacokinetics and bioavailability
Gugler, R., Manion, C. V., & Azarnoff, D. L. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1976192135 · Cited by 119
Bioavailability of oral dexamethasone
Duggan, D. E., Yeh, K. C., Matalia, N., Ditzler, C. A., & McMahon, F. G. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975182205 · Cited by 116
Ferron, G. M., Rochdi, M., Jusko, W. J., & Scherrmann, J. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04753.x · Cited by 116
Mihaly, G., Ward, S. A., Edwards, G., Nicholl, D., Orme, M., & Breckenridge, A. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02709.x · Cited by 115
Absorption Characteristics of Solid Dispersed and Micronized Griseofulvin in Man
Chiou, W. L., & Riegelman, S. (1971) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600600919 · Cited by 112
Pharmacokinetics and pharmacodynamics of allopurinol in elderly and young subjects
Turnheim, Krivanek, & Oberbauer (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00041.x · Cited by 109
Variable Furosemide Absorption and Poor Predictability of Response in Elderly Patients
Murray, M. D., Haag, K. M., Black, P., Hall, S. D., & Brater, D. C. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03681.x · Cited by 107
Os, E. C. V., Zins, B., Sandborn, W. J., Mays, D. C., Tremaine, W. J., Mahoney, D. W., Zinsmeister, A. R., & Lipsky, J. J. (1996) · Gut · doi:10.1136/gut.39.1.63 · Cited by 106
Clinical Pharmacokinetics of Metoclopramide
Bateman, D. N. (1983) · Clinical Pharmacokinetics · doi:10.2165/00003088-198308060-00003 · Cited by 105
Clinical Pharmacokinetics of Anthelmintic Drugs
Edwards, G., & Breckenridge, A. M. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198815020-00001 · Cited by 104
McDowell, J. A., Chittick, G. E., Ravitch, J. R., Polk, R. E., Kerkering, T. M., & Stein, D. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2855 · Cited by 102
Clinical Pharmacokinetics of Cholinesterase Inhibitors
Aquilonius, S., & Hartvig, P. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611030-00005 · Cited by 102
Jejunal Absorption and Metabolism of R/S-Verapamil in Humans
Sandström, R., Karlsson, A., Knutson, L., & Lennernäs, H. (1998) · Pharmaceutical Research · doi:10.1023/a:1011916329863 · Cited by 101
Lennernäs, H., Ahrenstedt, Ö., & Ungell, A. ‐. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04309.x · Cited by 101
Absolute Bioavailability of Oral and Intramuscular Diazepam
Divoll, M., Greenblatt, D. J., Ochs, H. R., & Shader, R. I. (1983) · Anesthesia & Analgesia · doi:10.1213/00000539-198301000-00001 · Cited by 101
Clinical pharmacokinetics of atenolol — A review
Kirch, W., & Görg, K. G. (1982) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03188723 · Cited by 100
Pharmacokinetics and bioavailability of oral and intramuscular artemether
Karbwang, J., Na‐Bangchang, K., Congpuong, K., Molunto, P., & Thanavibul, A. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050295 · Cited by 99
Clinical Pharmacokinetics of Chloramphenicol and Chloramphenicol Succinate
Ambrose, P. J. (1984) · Clinical Pharmacokinetics · doi:10.2165/00003088-198409030-00004 · Cited by 97
Pharmacokinetics of chlorpromazine and key metabolites
Yeung, P. K. F., Hubbard, J. W., Korchinski, E. D., & Midha, K. K. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315316 · Cited by 94
Clinical Pharmacokinetics of Antithyroid Drugs
Kampmann, J. P., & Hansen, J. (1981) · Clinical Pharmacokinetics · doi:10.2165/00003088-198106060-00001 · Cited by 91
Absorption, metabolism and excretion of pyrazinamide in man
Ellard, G. A. (1969) · Tubercle · doi:10.1016/0041-3879(69)90020-8 · Cited by 90
Mooradian, A. D. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198815030-00002 · Cited by 89
Pharmacokinetics, Absolute Bioavailability, and Absorption Characteristics of Lamivudine
Yuen, G. J., Morris, D. M., Mydlow, P. K., Haidar, S. H., Hall, S. T., & Hussey, E. K. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04043.x · Cited by 88
Struck, R. F., Alberts, D. S., Horne, K., Phillips, J. G., Peng, Y., & Roe, D. J. (1987) · PubMed · Cited by 88
Phenobarbital Pharmacokinetics and Bioavailability in Adults
NELSON, E., Powell, J. R., Conrad, K. A., Likes, K. E., Byers, J. M., BAKER, S., & Perrier, D. G. (1982) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1982.tb02662.x · Cited by 87
Vitamin A1 intestinal absorption in vivo: influence of luminal factors on transport.
Hollander, D., & Muralidhara, K. S. (1977) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1977.232.5.e471 · Cited by 87
Frick, A. D., Möller, H., & Wirbitzki, E. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00041-1 · Cited by 85
Roy, S. D., & Flynn, G. L. (1989) · Pharmaceutical Research · doi:10.1023/a:1015932610010 · Cited by 81
Lennernäs, H., Knutson, L., Knutson, T. W., Hussain, A., Lesko, L. J., Salmonson, T., & Amidon, G. L. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00005-2 · Cited by 81
Pharmacokinetics and Bioinversion of Ibuprofen Enantiomers in Humans
Cheng, H., Rogers, J., Demetriades, J. L., Holland, S. D., Seibold, J. R., & DePuy, E. (1994) · Pharmaceutical Research · doi:10.1023/a:1018969506143 · Cited by 79
Clinical Pharmacokinetics of Ergotamine in Migraine and Cluster Headache
Perrin, V. L. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510040-00004 · Cited by 79
Absolute and Relative Bioavailability of Oral Acetaminophen Preparations
Ameer, B., Divoll, M., Abernethy, D. R., Greenblatt, D. J., & Shargel, L. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600720832 · Cited by 79
Pharmacokinetics of Digoxin and Main Metabolites/Derivatives in Healthy Humans
Hinderling, P. H., & Hartmann, D. (1991) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199109000-00001 · Cited by 79
Greenblatt, D. J., Smith, T. W., & Koch‐Weser, J. (1976) · Clinical Pharmacokinetics · doi:10.2165/00003088-197601010-00004 · Cited by 78
Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability.
Nagy, J., Schipper, H. G., Koopmans, R. P., Butter, J. J., van Boxtel, C. J., & Kager, P. A. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.66.260 · Cited by 76
Effect of food on the bioavailability of triclabendazole in patients with fascioliasis
Lecaillon, J. B., Godbillon, J., Campestrini, J., Náquira, C., Miranda, L., Pacheco, R., Mull, R. P., & Poltera, A. A. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00725.x · Cited by 75
Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.
Graffner, C., Lagerström, P. O., Lundborg, P. G., & Rönn, O. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb01028.x · Cited by 75
O’Sullivan, B. T., Cutler, D. J., Hunt, G. E., Walters, C. A., Johnson, G. F. S., & Caterson, I. D. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00094-7 · Cited by 75
Implications of intraindividual variability in bioavailability studies of furosemide
Grahn�n, A., Hammarlund, M., & Lundqvist, T. (1984) · European Journal of Clinical Pharmacology · doi:10.1007/bf00556898 · Cited by 73
Haloperidol kinetics after oral and intravenous doses
Holley, F. O., Magliozzi, J. R., Stanski, D. R., Lombrozo, L., & Hollister, L. E. (1983) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1983.65 · Cited by 73
Pharmacokinetics of chlorpheniramine after intravenous and oral administration in normal adults
Huang, S. M., Athanikar, N. K., Sridhar, K., Huang, Y., & Chiou, W. L. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00548406 · Cited by 72
Pyridostigmine kinetics in healthy subjects and patients with myasthenia gravis
Breyer-Pfaff, U., Maier, U., BRINKMANN, A., et al. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.78 · Cited by 68
Human Thyroxine Absorption: Age Effects and Methodological Analyses
HAYS, M. T., & NIELSEN, K. R. K. (1994) · Thyroid · doi:10.1089/thy.1994.4.55 · Cited by 67
The bioavailability of26Al-labelled aluminium citrate and aluminium hydroxide in volunteers
Priest, N. D., Talbot, R. J. E., Austin, J. G., Day, J., King, S. J., Fifield, L. K., & Cresswell, R. G. (1996) · BioMetals · doi:10.1007/bf00817919 · Cited by 67
Clinical Pharmacokinetics of D-Penicillamine
Netter, P., Bannwarth, B., Péré, P., et al. (1987) · Clinical Pharmacokinetics · doi:10.2165/00003088-198713050-00003 · Cited by 67
Martin, W., Koselowske, G., Töberich, H., et al. (1990) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510110311 · Cited by 65
Human Jejunal Permeability of Two Polar Drugs: Cimetidine and Ranitidine
Takamatsu, N., Kim, O., Welage, L. S., Idkaidek, N., Hayashi, Y., Barnett, J. L., YAMAMOTO, R., Lipka, E., Lennernäs, H., Hussain, A. S., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1011020025338 · Cited by 64
Westerling, D., Persson, C. G. A., & Höglund, P. (1995) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199506000-00013 · Cited by 63
Clinical Pharmacokinetics of Stavudine
Rana, K. Z., & Dudley, M. N. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733040-00003 · Cited by 61
Chin, T. W., Vandenbroucke, A., & Fong, I. W. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.28 · Cited by 61
Takamatsu, N., Welage, L. S., Idkaidek, N., Liu, D.-Y., Lee, P. I.-D., Hayashi, Y., Rhie, J. K., Lennernäs, H., Barnett, J. L., Shah, V. P., et al. (1997) · Pharmaceutical Research · doi:10.1023/a:1012134219095 · Cited by 60
Meal Composition Effects on the Oral Bioavailability of Indinavir in HIV-Infected Patients
Carver, P. L., Fleisher, D., Zhou, S. Y., Kaul, D. R., Kazanjian, P. H., & Li, C. (1999) · Pharmaceutical Research · doi:10.1023/a:1018880726035 · Cited by 59
Bode, H., Brendel, E., Ahr, G., Fuhr, U., Harder, S., & Staib, A. H. (1996) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050092 · Cited by 59
Abacavir: Absolute Bioavailability, Bioequivalence of Three Oral Formulations, and Effect of Food
Chittick, G. E., Gillotin, C., McDowell, J. A., Lou, Y., Edwards, K. D., Prince, W., & Stein, D. S. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.11.932.31568 · Cited by 58
Kinetics of allopurinol after single intravenous and oral doses
Breithaupt, H., & Tittel, M. (1982) · European Journal of Clinical Pharmacology · doi:10.1007/bf00606429 · Cited by 57
The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomy
Grimmer, S. F. M., Back, D. J., Orme, M. L., Cowie, A. M., Gilmore, I. T., & Tjia, J. (1986) · Contraception · doi:10.1016/0010-7824(86)90032-6 · Cited by 54
Grimaldi, R., Perucca, E., Ruberto, G., Gelmi, C., Trimarchi, F., Hollmann, M., & Crema, A. (1986) · European Journal of Clinical Pharmacology · doi:10.1007/bf00615970 · Cited by 51
Clinical Pharmacokinetics of Methyldopa
Myhre, E., Rugstad, H. E., & Hansen, T. (1982) · Clinical Pharmacokinetics · doi:10.2165/00003088-198207030-00003 · Cited by 50
The Pharmacokinetics of Propylthiouracil
Kampmann, J. P., & Skovsted, L. (1974) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1974.tb00756.x · Cited by 49
Pharmacokinetics of High-dose Oral and Intravenous Dexamethasone
Tóth, G. G., Kloosterman, C., Uges, D. R. A., et al. (1999) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199910000-00007 · Cited by 48
Pharmacokinetics of a nitrofuran compound, nifurtimox, in healthy volunteers.
Paulos, C., Paredes, J. O. M., Vásquez, I., Thambo, S., Arancibia, A., & González-Martin, G. (1989) · PubMed · Cited by 46
The pharmacokinetics and bioavailability of a tracer dose of [3H]‐ mebendazole in man.
Dawson, M., Braithwaite, P., Roberts, M. S., & Watson, T. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02616.x · Cited by 44
The Anthelminthic Agent Albendazole Does Not Interact with P-Glycoprotein
Merino, G., Álvarez, A. I., Prieto, J. G., & Kim, R. B. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.4.365 · Cited by 44
Tett, S. E., Moore, S., & Ray, J. E. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1835 · Cited by 44
Shelton, M. J., O'Donnell, A. M., & Morse, G. D. (1992) · Annals of Pharmacotherapy · doi:10.1177/106002809202600511 · Cited by 44
Bittner, B., Guenzi, A., Fullhardt, P., Zürcher, G., González, R., & Mountfield, R. J. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1299951 · Cited by 43
On the absorption of ascorbic acid in man.
Kallner, A., Hartmann, D., & Hornig, D. H. (1977) · PubMed · Cited by 43
Hoener, B., & Patterson, S. E. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.115 · Cited by 43
Dicloxacillin and cloxacillin: Pharmacokinetics in healthy and hemodialysis subjects
Nauta, E. H., & Mattie, H. (1976) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197620198 · Cited by 42
Diazepam absorption: Effects of age, sex, and Billroth gastrectomy
Ochs, H. R., Otten, H., Greenblatt, D. J., & Dengler, H. J. (1982) · Digestive Diseases and Sciences · doi:10.1007/bf01296920 · Cited by 41
Plasma kinetics of vitamin A in humans after a single oral dose of [8,9,19-13C]retinyl palmitate
von Reinersdorff, D., Bush, E. D., & Liberato, D. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37552-0 · Cited by 41
Bioavailability and pharmacokinetics of D-penicillamine.
Kukovetz, W. R., Beubler, E., Kreuzig, F., et al. (1983) · PubMed · Cited by 41
Pharmacokinetics of levamisole.
Adams, J. (1978) · PubMed · Cited by 40
Safety and pharmacokinetics of single oral and intravenous doses of fluconazole in healthy subjects.
Shiba, K., Saito, A., & Miyahara, T. (1990) · PubMed · Cited by 40
Back, D. J., Grimmer, S. F. M., Rogers, S. N., Stevenson, P. J., & Orme, M. L. (1987) · Contraception · doi:10.1016/0010-7824(87)90095-3 · Cited by 36
Dawson, M., Allan, R., & Watson, T. (1982) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1982.tb02008.x · Cited by 35
Which form of erythromycin should be used to treat gastroparesis? A pharmacokinetic analysis
Ehrenpreis, Zaitman, & Nellans (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00302.x · Cited by 34
Pharmacokinetics of acetazolamide after intravenous and oral administration in horses
Alberts, M. K., Clarke, C. R., MacAllister, C. G., & Homer, L. M. (2000) · American Journal of Veterinary Research · doi:10.2460/ajvr.2000.61.965 · Cited by 33
Absolute bioavailability of paracetamol after oral or rectal administration in healthy volunteers.
Eandi, M., Viano, I., & Gamalero, S. R. (1984) · PubMed · Cited by 32
Gastrointestinal metabolism of contraceptive steroids
Back, D. J., Madden, S., & Orme, M. L. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90554-k · Cited by 32
Pharmacokinetics of Ethosuximide in the Dog
Sayed, M. A. E. (1978) · Springer eBooks · doi:10.1007/978-3-662-39532-5_225 · Cited by 31
Knupp, C. A., Shyu, W. C., Morgenthien, E. A., Lee, J. S., & Barbhaiya, R. H. (1993) · Pharmaceutical Research · doi:10.1023/a:1018964117665 · Cited by 28
Somogyi, A. A., Bochner, F., Hetzel, D. J., & Williams, D. B. (1995) · Pharmaceutical Research · doi:10.1023/a:1016215510223 · Cited by 28
Chronopharmacology of intravenous and oral modified release verapamil
Dilger, K., Eckhardt, K., Hofmann, U., Kucher, K., Mikus, G., & Eichelbaum, M. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00910.x · Cited by 27
Hasselström, K., Siersbæk‐Nielsen, K., Lumholtz, B., Faber, J. O., KIRKEGAARD, C., & Friis, T. (1985) · European Journal of Endocrinology · doi:10.1530/acta.0.1100483 · Cited by 25
Pharmacokinetics and pharmacodynamics of isosorbide dinitrate
Fung, H. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90489-2 · Cited by 20
Clinical Pharmacokinetics of Co-Trimazine
Bergan, T., Örtengren, B., & Westerlund, D. (1986) · Clinical Pharmacokinetics · doi:10.2165/00003088-198611050-00003 · Cited by 20
The pharmacokinetics of fluocortolone and prednisolone after intravenous and oral administration.
Täuber, U., Haack, D., Nieuweboer, B., Kloss, G., Vecsei, P., & Wendt, H. (1984) · PubMed · Cited by 18
Tukker, J. J., Sitsen, J. M. A., & Gusdori, C. F. (1986) · Pharmacy World & Science · doi:10.1007/bf01957785 · Cited by 17
Patel, I. H., Levy, R. H., & Bauer, T. G. (1975) · Epilepsia · doi:10.1111/j.1528-1157.1975.tb04755.x · Cited by 14
[Absolute bioavailability of chlorpromazine, promazine and promethazine].
Koytchev, R., Alken, R. G., Kirkov, V., Neshev, G., Vagaday, M., & Kunter, U. (1994) · PubMed · Cited by 13
Saturable First‐Pass Kinetics of Propranolol
Keller, F., Kunzendorf, U., Walz, G., Haller, H. G., & Offermann, G. (1989) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1989.tb03320.x · Cited by 9
The demethylation of amitriptyline administered by oral and intramuscular routes
Burch, J., & HERRIES, D. G. (1983) · Psychopharmacology · doi:10.1007/bf00436163 · Cited by 7
Maxon, H. R., Ritschel, W. A., Volle, C. P., Eldon, M. A., Iw, C., Mf, F., Cline, J. M., & Mayfield, G. E. (1983) · PubMed · Cited by 6
Hs, K., Kehrhahn, O. H., Neugebauer, G., Schuppan, D., Schwarz, J. A., & Staib, A. H. (1984) · PubMed · Cited by 5
Cited by
Wu, C.-Y., & Benet, L. Z. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9004-4 · Cited by 1,401
Dokoumetzidis, A., & Macheras, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.011 · Cited by 715
Takagi, T., Ramachandran, C., Bermejo, M., Yamashita, S., Yu, L. X., & Amidon, G. L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp0600182 · Cited by 606
The Use of Biorelevant Dissolution Media to Forecast the In Vivo Performance of a Drug
Klein, S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9203-3 · Cited by 458
Dahan, A., Miller, J. M., & Amidon, G. L. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9144-x · Cited by 453
Metadata
- Authors
- Lindenberg, M., Kopp, S., & Dressman, J. B.
- Venue
- European Journal of Pharmaceutics and Biopharmaceutics
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 58
- Issue
- 2
- Pages
- 265-278
- ISSN
- 0939-6411 (ISSN-L)
- OpenAlex
- W2064288191
- Cited by
- 864
- References
- 156
- FWCI
- 13.29
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.